Latest Posts › Infectious Diseases

Share:

Covid–19 coronavirus: global merger review (updated 13 November 2020)

Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19. While critical transactions are likely to be reviewed, as far as possible, in...more

Covid–19 coronavirus update: an overview of European Commission State aid decisions (updated 13 November 2020)

Under State aid rules, UK and EEA Member State governments may not generally provide selective assistance to businesses without prior approval from the European Commission (EC). This includes assistance in the form of...more

Covid–19 coronavirus update: global application of antitrust rules (updated 13 November 2020)

Adverse economic or social conditions have not historically tended to affect the general application and enforcement of antitrust rules. This remains the overall position in the circumstances of Covid-19, with many antitrust...more

Covid–19 coronavirus update: global application of antitrust rules (updated)

Adverse economic or social conditions have not historically tended to affect the general application and enforcement of antitrust rules. This remains the overall position in the circumstances of Covid-19, with many antitrust...more

Covid–19 coronavirus: global merger review update (updated)

Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19. While critical transactions are likely to be reviewed, as far as possible, in...more

Covid–19 coronavirus update: Global application of antitrust rules

Adverse economic or social conditions have not historically tended to affect the general application and enforcement of antitrust rules. This remains the overall position in the circumstances of Covid-19, with many antitrust...more

Covid–19 coronavirus: Global merger review update

Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible,...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide